INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 204 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $237,000 | -49.1% | 3,763 | 0.0% | 0.06% | -39.6% |
| Q4 2019 | $466,000 | +86.4% | 3,763 | 0.0% | 0.09% | +78.4% |
| Q3 2019 | $250,000 | -16.4% | 3,763 | 0.0% | 0.05% | -19.0% |
| Q2 2019 | $299,000 | -29.0% | 3,763 | 0.0% | 0.06% | -40.6% |
| Q1 2019 | $421,000 | -27.5% | 3,763 | -34.7% | 0.11% | -43.9% |
| Q4 2018 | $581,000 | -20.2% | 5,763 | 0.0% | 0.19% | +0.5% |
| Q3 2018 | $728,000 | +50.4% | 5,763 | 0.0% | 0.19% | +35.3% |
| Q2 2018 | $484,000 | -30.1% | 5,763 | -48.8% | 0.14% | +90.4% |
| Q1 2018 | $692,000 | -14.5% | 11,254 | -18.8% | 0.07% | +58.7% |
| Q4 2017 | $809,000 | -33.1% | 13,854 | -33.6% | 0.05% | +2.2% |
| Q3 2017 | $1,210,000 | -60.3% | 20,854 | -17.2% | 0.04% | -44.4% |
| Q2 2017 | $3,049,000 | -51.3% | 25,184 | -54.5% | 0.08% | -58.5% |
| Q1 2017 | $6,263,000 | -7.5% | 55,380 | -11.1% | 0.20% | -5.3% |
| Q4 2016 | $6,770,000 | -55.2% | 62,306 | -32.2% | 0.21% | -63.9% |
| Q3 2016 | $15,123,000 | +44.7% | 91,881 | +25.4% | 0.57% | -20.7% |
| Q2 2016 | $10,450,000 | +1.6% | 73,243 | -8.5% | 0.72% | +13.9% |
| Q1 2016 | $10,283,000 | +1519.4% | 80,044 | +1782.9% | 0.63% | +1652.8% |
| Q4 2015 | $635,000 | -9.9% | 4,251 | 0.0% | 0.04% | +50.0% |
| Q3 2015 | $705,000 | -31.3% | 4,251 | 0.0% | 0.02% | +50.0% |
| Q2 2015 | $1,026,000 | -14.4% | 4,251 | 0.0% | 0.02% | -76.1% |
| Q1 2015 | $1,199,000 | +80.8% | 4,251 | 0.0% | 0.07% | +103.0% |
| Q4 2014 | $663,000 | -34.1% | 4,251 | 0.0% | 0.03% | -36.5% |
| Q3 2014 | $1,006,000 | 0.0% | 4,251 | 0.0% | 0.05% | -3.7% |
| Q2 2014 | $1,006,000 | -28.2% | 4,251 | 0.0% | 0.05% | -32.5% |
| Q1 2014 | $1,402,000 | – | 4,251 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |